ZA200810124B - Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and Paracetamol - Google Patents
Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and ParacetamolInfo
- Publication number
- ZA200810124B ZA200810124B ZA200810124A ZA200810124A ZA200810124B ZA 200810124 B ZA200810124 B ZA 200810124B ZA 200810124 A ZA200810124 A ZA 200810124A ZA 200810124 A ZA200810124 A ZA 200810124A ZA 200810124 B ZA200810124 B ZA 200810124B
- Authority
- ZA
- South Africa
- Prior art keywords
- paracetamol
- phenol
- propyl
- ethyl
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06008851 | 2006-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200810124B true ZA200810124B (en) | 2009-08-26 |
Family
ID=37025148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200810124A ZA200810124B (en) | 2006-04-28 | 2008-11-27 | Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and Paracetamol |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP2012764B1 (xx) |
JP (2) | JP5496653B2 (xx) |
KR (1) | KR101396166B1 (xx) |
CN (1) | CN101431990B (xx) |
AT (1) | ATE494889T1 (xx) |
AU (1) | AU2007247481B2 (xx) |
BR (1) | BRPI0710682B8 (xx) |
CA (1) | CA2650423C (xx) |
CY (1) | CY1111369T1 (xx) |
DE (1) | DE602007011913D1 (xx) |
DK (1) | DK2012764T3 (xx) |
EC (2) | ECSP088793A (xx) |
ES (1) | ES2356093T3 (xx) |
HK (1) | HK1127289A1 (xx) |
HR (1) | HRP20110076T1 (xx) |
IL (1) | IL194883A (xx) |
MX (1) | MX2008013779A (xx) |
NO (2) | NO341602B1 (xx) |
NZ (1) | NZ571442A (xx) |
PL (1) | PL2012764T3 (xx) |
PT (1) | PT2012764E (xx) |
RU (1) | RU2442576C2 (xx) |
SI (1) | SI2012764T1 (xx) |
WO (1) | WO2007128413A1 (xx) |
ZA (1) | ZA200810124B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007012165A1 (de) | 2007-03-12 | 2008-09-18 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes |
EP2219633A2 (en) * | 2007-11-23 | 2010-08-25 | Nectid, Inc. | Tapentadol compositions |
KR101831616B1 (ko) | 2010-06-15 | 2018-04-04 | 그뤼넨탈 게엠베하 | 통증 치료용 약제학적 병용물 |
MX351584B (es) | 2011-03-04 | 2017-10-20 | Gruenenthal Gmbh | Formulacion farmaceutica acuosa de tapentadol para administracion oral. |
US20120225951A1 (en) * | 2011-03-04 | 2012-09-06 | Gruenenthal Gmbh | Parenteral Administration of Tapentadol |
EP2680834B1 (en) | 2011-03-04 | 2017-10-18 | Grünenthal GmbH | Semisolid aqueous pharmaceutical composition containing tapentadol |
US9320729B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
US20130310435A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol |
US9855286B2 (en) | 2012-05-18 | 2018-01-02 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
US20130310385A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants |
EP2808319A1 (en) | 2013-05-31 | 2014-12-03 | Arevipharma GmbH | 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex |
LT3273953T (lt) | 2015-03-27 | 2019-02-25 | Grünenthal GmbH | Stabili kompozicija, skirta tapentadolio skyrimui parenteriniu būdu |
EP3515412A1 (en) | 2016-09-23 | 2019-07-31 | Grünenthal GmbH | Stable formulation for parenteral administration of tapentadol |
EP3585370A1 (en) | 2017-02-23 | 2020-01-01 | Grünenthal GmbH | Tapentadol as local anesthetic |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
PE20030527A1 (es) * | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
EP1685829B1 (de) * | 2002-11-22 | 2008-04-09 | Grünenthal GmbH | Verwendung von (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexan-1,3-diol zur Behandlung von Entzündungsschmerz |
-
2007
- 2007-04-25 WO PCT/EP2007/003632 patent/WO2007128413A1/en active Application Filing
- 2007-04-25 AT AT07724562T patent/ATE494889T1/de active
- 2007-04-25 MX MX2008013779A patent/MX2008013779A/es active IP Right Grant
- 2007-04-25 RU RU2008146816/15A patent/RU2442576C2/ru active
- 2007-04-25 ES ES07724562T patent/ES2356093T3/es active Active
- 2007-04-25 DE DE602007011913T patent/DE602007011913D1/de active Active
- 2007-04-25 CA CA2650423A patent/CA2650423C/en active Active
- 2007-04-25 PT PT07724562T patent/PT2012764E/pt unknown
- 2007-04-25 NZ NZ571442A patent/NZ571442A/en unknown
- 2007-04-25 KR KR1020087028929A patent/KR101396166B1/ko active IP Right Grant
- 2007-04-25 BR BRPI0710682A patent/BRPI0710682B8/pt active IP Right Grant
- 2007-04-25 PL PL07724562T patent/PL2012764T3/pl unknown
- 2007-04-25 CN CN2007800148115A patent/CN101431990B/zh active Active
- 2007-04-25 DK DK07724562.9T patent/DK2012764T3/da active
- 2007-04-25 EP EP07724562A patent/EP2012764B1/en active Active
- 2007-04-25 AU AU2007247481A patent/AU2007247481B2/en active Active
- 2007-04-25 SI SI200730498T patent/SI2012764T1/sl unknown
- 2007-04-25 JP JP2009506978A patent/JP5496653B2/ja active Active
-
2008
- 2008-10-06 EC EC2008008793A patent/ECSP088793A/es unknown
- 2008-10-23 IL IL194883A patent/IL194883A/en active IP Right Grant
- 2008-10-28 NO NO20084542A patent/NO341602B1/no unknown
- 2008-11-27 ZA ZA200810124A patent/ZA200810124B/xx unknown
-
2009
- 2009-06-25 HK HK09105733.2A patent/HK1127289A1/xx unknown
-
2011
- 2011-02-01 HR HR20110076T patent/HRP20110076T1/hr unknown
- 2011-04-05 CY CY20111100353T patent/CY1111369T1/el unknown
-
2013
- 2013-07-11 JP JP2013145481A patent/JP2013213045A/ja not_active Withdrawn
-
2017
- 2017-01-05 EC ECIEPI2017643A patent/ECSP17000643A/es unknown
- 2017-11-17 NO NO20171831A patent/NO343505B1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP17000643A (es) | Combinación farmacéutica que comprende 3-(3-dimetilamino-1etil-2-metil-propil)-fenol y Paracetamol. | |
MX2008013828A (es) | Combinacion farmaceutica que comprende 3-(3-dimetilanimo-1-etil-2- metil-propil)-fenol y un nsaid. | |
WO2010025931A3 (en) | Pharmaceutical combination of 3- (3-dimethylamino-1-ethyl-2 -methyl-propyl) - phenol and an antiepileptic | |
AU2016219643A1 (en) | Pharmaceutical combination for the treatment of pain | |
WO2007070052A3 (en) | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease | |
WO2013158680A3 (en) | Compositions and methods comprising celecoxib or related compounds and dextromethorphan | |
WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
EA200900264A1 (ru) | Композиции флибансерина и способ их приготовления | |
BRPI0922789A2 (pt) | peptídeo de ligação de albumina intermediador para reconhecimento de doença | |
WO2008131056A3 (en) | Sustained release monoeximic formulations of opioid and nonopioid analgesics | |
RS52867B (en) | GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS | |
WO2007138466A3 (en) | Pharmaceutical compositions comprising meloxicam and tramadol combination | |
WO2008124505A3 (en) | Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders | |
UA103614C2 (uk) | Лікарський засіб, що містить комбінацію інгібітора кінази та анти-гліпікан 3-антитіла, для лікування раку печінки | |
WO2006138608A3 (en) | Pharmaceutical compositions and use thereof | |
WO2006055352A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally | |
HK1176318A1 (en) | Injection device | |
WO2007056236A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intravenously | |
MX2009011900A (es) | Curacion de herida diabetica. | |
WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
WO2008012796A3 (en) | Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation | |
WO2008075320A3 (en) | Antilipidemic pharmaceutical compositions and process for preparation thereof | |
WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
TW200744676A (en) | Pharmaceutical compositions for the eradication of helicobacter pylori | |
WO2007084383A3 (en) | Method and composition for the treatment of parkinson's disease |